Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 3217Carcinoma, Non-Small-Cell Lung 2731Breast Neoplasms 2553Colorectal Neoplasms 1464Prostatic Neoplasms 1310Neoplasm Metastasis 1302Multiple Myeloma 1112Melanoma 1102Ovarian Neoplasms 1006Lung Neoplasms 946Recurrence 924Leukemia, Myeloid, Acute 878Pancreatic Neoplasms 833Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 693Carcinoma, Renal Cell 661Carcinoma, Hepatocellular 648Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 516Head and Neck Neoplasms 491Glioblastoma 473Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 436Advanced Solid Tumors 433Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

motesanib diphosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Histologically or Cytologically Documented Solid Tumors × Clear all
NCT01235416 2011-01-21

A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors

Amgen

Phase 1 Completed
57 enrolled
Other solid neoplasm

Histologically or Cytologically Documented Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡